|
ZNF8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.659200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.831240E-01 |
| Normal-vs-Stage2 |
5.559800E-01 |
| Normal-vs-Stage3 |
1.643640E-01 |
| Normal-vs-Stage4 |
6.992300E-02 |
| Stage1-vs-Stage2 |
8.913400E-01 |
| Stage1-vs-Stage3 |
5.839400E-03 |
| Stage1-vs-Stage4 |
2.921900E-03 |
| Stage2-vs-Stage3 |
1.499560E-01 |
| Stage2-vs-Stage4 |
8.196100E-02 |
| Stage3-vs-Stage4 |
6.070800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.172200E-01 |
| Normal-vs-AfricanAmerican |
3.637000E-01 |
| Normal-vs-Asian |
5.321900E-02 |
| Caucasian-vs-AfricanAmerican |
2.652000E-01 |
| Caucasian-vs-Asian |
1.470820E-01 |
| AfricanAmerican-vs-Asian |
3.178200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.079000E-01 |
| Normal-vs-Female |
3.141000E-01 |
| Male-vs-Female |
7.766000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.900000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.030400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.125600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.626400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.461400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.636800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.879200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.976100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.053800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.180400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.572800E-04 |
| Normal-vs-Grade 2 |
1.743780E-01 |
| Normal-vs-Grade 3 |
2.986400E-01 |
| Normal-vs-Grade 4 |
7.396000E-02 |
| Grade 1-vs-Grade 2 |
4.986200E-02 |
| Grade 1-vs-Grade 3 |
1.880020E-03 |
| Grade 1-vs-Grade 4 |
5.213000E-04 |
| Grade 2-vs-Grade 3 |
9.937200E-03 |
| Grade 2-vs-Grade 4 |
5.464800E-03 |
| Grade 3-vs-Grade 4 |
3.072400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.178230E-01 |
| Normal-vs-ccB subtype |
3.510800E-01 |
| ccA subtype-vs-ccB subtype |
8.540700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.816000E-01 |
| Normal-vs-N1 |
5.075500E-02 |
| N0-vs-N1 |
1.295950E-01 |
|
|
